PharmGKB summary: acyclovir/ganciclovir pathway
Pharmacogenet Genomics
.
2022 Jul 1;32(5):201-208.
doi: 10.1097/FPC.0000000000000474.
Epub 2022 May 30.
Authors
Maud Maillard
1
,
Li Gong
2
,
Rina Nishii
1
,
Jun J Yang
1
,
Michelle Whirl-Carrillo
2
,
Teri E Klein
2
3
Affiliations
1
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
2
Departments of Biomedical Data Science.
3
Medicine (BMIR), Stanford University, Stanford, California, USA.
PMID:
35665708
PMCID:
PMC9179945
DOI:
10.1097/FPC.0000000000000474
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Acyclovir* / therapeutic use
Antiviral Agents / therapeutic use
Ganciclovir*
Humans
Substances
Antiviral Agents
Ganciclovir
Acyclovir
Grants and funding
R35 GM141947/GM/NIGMS NIH HHS/United States
U24 HG010615/HG/NHGRI NIH HHS/United States